CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

HDFC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
17.31 -0.18(-1.05%) NAV as on 09 Jan 2026
0.69 % 1 M
2.89 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.09

As on 30 Nov, 2025
age-icon Age :

2 yrs 3 m

Since 04 10 ,2023
exit_load Exit Load :

1%

aum AUM :

1,983.91 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.9

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Nikhil Mathur

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2025
Others 2.21 %
Equity 97.79 %

TOP HOLDINGS

Sun Pharmaceutical Industries...10.79 %
Divi's Laboratories Ltd.8.35 %
Glenmark Pharmaceuticals Ltd.6.45 %
Lupin Ltd.6.04 %
Alkem Laboratories Ltd.5.78 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs71.37
Hospital & Healthcare Services24.45
Miscellaneous1.09
Medical Equipment/Supplies/Accessories0.88
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-20252025-2026
NAV in Rs (as on 09-Jan-2026)12.2915.9217.31
Net Assets(Rs Crores) (as on 09-Jan-2026) 800.65 1634.08 1983.91
Scheme Returns(%)(Absolute)23.3028.3510.59
B'mark Returns(%)(Absolute)NANANA
Category Rank66/901/10248/113

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity17.31-0.18(-1.05%)NAV As on 09 Jan, 202604-Oct-2023Inception Date1,983.91AUM In Cr.2.89%1YNA%3YNA%5Y27.55%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.43-0.33(-0.83%)NAV As on 09 Jan, 202613-Jul-2018Inception Date6,455.55AUM In Cr.-0.05%1Y26.84%3Y16.74%5Y20.08%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity421.23-4.12(-0.97%)NAV As on 09 Jan, 202614-Jul-1999Inception Date3,989.42AUM In Cr.-3.70%1Y23.38%3Y15.60%5Y15.87%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity38.44-0.41(-1.05%)NAV As on 09 Jan, 202602-Jul-2018Inception Date2,770.84AUM In Cr.-1.38%1Y21.67%3Y14.59%5Y19.58%Since Inception
Nippon India Pharma Fund(G)Very HighEquity510.07-3.56(-0.69%)NAV As on 09 Jan, 202605-Jun-2004Inception Date8,264.71AUM In Cr.-2.15%1Y21.66%3Y14.26%5Y19.95%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.